LunaDNA Competitors and Similar CompaniesClear all
LunaDNA's competitors and similar companies include Patientory, Precision BioSciences, Optra Health and StrideBio.
 Patientory Patientory provides an online healthcare information platform intended to connect users of similar health interests via their health information. |  Precision BioSciences Precision BioSciences is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. |  StrideBio StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases. | |||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2006 | Founding Date 2014 | Founding Date 2015 |
Type | Type Subsidiary | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ San Diego, US | Locations Duluth, US HQ | Locations HQ Durham, US | Locations Los Angeles, US HQ San Jose, US San Jose, US | Locations US HQ |
Employees | Employees 11 | Employees 157% increase | Employees 1998% increase | Employees 711% decrease | Employees 5 |
Funding | |||||
Total funding raised | Total funding raised $ 8.6m | Total funding raised $ 7.2m | Total funding raised $ 175.2m | Total funding raised N/A | Total funding raised $ 97.2m |
For sources of this data, please see the company profile
View Company Profiles
Patientory
HQ
Duluth, US
Employees
15↑ 7% increase
Patientory provides an online healthcare information platform intended to connect users of similar health interests via their health information.
View companyPrecision BioSciences
HQ
Employees
199↑ 8% increase
Precision BioSciences is a genome editing company dedicated to improving life through its genome editing platform, ARCUS.
View company
Optra Health
HQ
Los Angeles, US
Employees
71↓ 1% decrease
Optra Health is a technology company developing a conversational AI tool.
View companyStrideBio
HQ
US
Employees
5
StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.
View company